Atyr Pharma Inc (ATYR)

Mar 12, 2026

Does aTyr Pharma Inc stock benefit from AI growth2026 Analyst Calls & Precise Entry and Exit Recommendations - baoquankhu1.vn

Mar 12, 2026

Mar 12, 2026

aTyr Pharma (NASDAQ: ATYR) asks shareholders to double authorized shares to 340M - Stock Titan

Mar 12, 2026

Mar 12, 2026

aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting - MarketBeat

Mar 12, 2026

Mar 10, 2026

Investigation announced for Long-Term Investors in shares - openPR.com

Mar 10, 2026

Mar 09, 2026

Q1 Earnings Estimate for aTyr Pharma Issued By HC Wainwright - MarketBeat

Mar 09, 2026

Mar 07, 2026

Atyr Pharma Faces Nasdaq Delisting Risk After Minimum Bid Price Violation - TipRanks

Mar 07, 2026

Mar 06, 2026

Jefferies Maintains Buy on ATYR aTyr Pharma, Inc. March 2026 - Meyka

Mar 06, 2026

Mar 06, 2026

Jefferies reiterates aTyr Pharma stock rating on regulatory outlook By Investing.com - Investing.com Canada

Mar 06, 2026

Mar 06, 2026

Jefferies reiterates aTyr Pharma stock rating on regulatory outlook - Investing.com UK

Mar 06, 2026

Mar 06, 2026

aTyr Pharma 2025 Financials: Q4 Loss Narrows, Annual Revenue SteadyNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Mar 06, 2026

Mar 05, 2026

Atyr Pharma: Fourth Quarter Earnings Overview - Bitget

Mar 05, 2026

Mar 05, 2026

aTyr Pharma (NASDAQ:ATYR) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Mar 05, 2026

Mar 05, 2026

aTyr (ATYR) Achieves Milestone with Phase 3 Study Results - GuruFocus

Mar 05, 2026

Mar 05, 2026

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update - The Manila Times

Mar 05, 2026

Mar 05, 2026

Atyr Pharma: Q4 Earnings Snapshot - marketscreener.com

Mar 05, 2026

Mar 05, 2026

ATyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update - marketscreener.com

Mar 05, 2026

Mar 05, 2026

aTyr Pharma (ATYR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Mar 05, 2026

Mar 04, 2026

ATYR Financials: Income Statement, Balance Sheet & Cash Flow | Atyr Pharma Inc - Stock Titan

Mar 04, 2026

Feb 28, 2026

ATYR PE Ratio & Valuation, Is ATYR Overvalued - Intellectia AI

Feb 28, 2026

Feb 28, 2026

aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Feb 28, 2026

Feb 27, 2026

aTyr Pharma Faces Pivotal Regulatory and Financial Milestones - AD HOC NEWS

Feb 27, 2026

Feb 26, 2026

aTyr Pharma (ATYR) Stock Analysis: Exploring a Potential 327% Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 26, 2026

Feb 25, 2026

aTyr Pharma Q4 2025 Earnings Call Transcript - MarketBeat

Feb 25, 2026

Feb 25, 2026

aTyr Pharma (NASDAQ:ATYR) Trading Down 2.1%Should You Sell? - MarketBeat

Feb 25, 2026

Feb 20, 2026

ATyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Feb 20, 2026

Feb 20, 2026

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 20, 2026

Feb 20, 2026

aTyr Pharma, Inc. (ATYR) Stock Analysis: Unveiling a Potential 338% Upside in the Biotechnology Arena - DirectorsTalk Interviews

Feb 20, 2026

Feb 18, 2026

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference - Bitget

Feb 18, 2026

Feb 18, 2026

aTyr Pharma Insiders Added US$926.8k Of Stock To Their Holdings - simplywall.st

Feb 18, 2026

Feb 18, 2026

ATyr Pharma to Present at the Leerink Partners Global Healthcare Conference - marketscreener.com

Feb 18, 2026

Feb 16, 2026

Sentiment Recap: Does aTyr Pharma Inc stock benefit from AI growth2025 Volatility Report & AI Forecast Swing Trade Picks - baoquankhu1.vn

Feb 16, 2026

Feb 15, 2026

Levels Update: Will CompoSecure Inc Equity Warrant stock go up in YEARVolume Spike & Low Volatility Stock Recommendations - baoquankhu1.vn

Feb 15, 2026

Feb 15, 2026

The Truth About aTyr Pharma Inc (LIFE): Tiny Stock, Huge Bets – But Is It Worth the Hype? - AD HOC NEWS

Feb 15, 2026

Feb 14, 2026

Is aTyr Pharma Inc. stock cheap compared to fundamentalsQuarterly Risk Review & Verified Swing Trading Watchlist - mfd.ru

Feb 14, 2026

Feb 14, 2026

Is aTyr Pharma Inc. backed by strong institutional buyingWeekly Trend Report & Smart Investment Allocation Tips - mfd.ru

Feb 14, 2026

Feb 14, 2026

Why hedge funds are buying aTyr Pharma Inc. stock2025 EndofYear Setup & Risk Managed Investment Entry Signals - mfd.ru

Feb 14, 2026

Feb 13, 2026

Why analysts upgrade aTyr Pharma Inc. stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - mfd.ru

Feb 13, 2026

Feb 13, 2026

Facioscapulohumeral Muscular Dystrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Dyne Therapeutics, miRecule, Avidity Biosciences, aTyr Pharma, Fulcrum Therapeutics - Barchart.com

Feb 13, 2026

Feb 13, 2026

Facioscapulohumeral Muscular Dystrophy Market: High-Growth - openPR.com

Feb 13, 2026

Feb 13, 2026

Is aTyr Pharma Inc. stock resilient to inflationJuly 2025 Market Mood & High Accuracy Trade Alerts - mfd.ru

Feb 13, 2026

Feb 06, 2026

Weekly Buzz: ATYR To Meet With FDA, SGMO Aces Fabry Study, AQST's Anaphylm Gets Rejected - RTTNews

Feb 06, 2026

Feb 06, 2026

Aug Summary: Does aTyr Pharma Inc have pricing powerJuly 2025 Reactions & Community Consensus Trade Signals - baoquankhu1.vn

Feb 06, 2026

Feb 05, 2026

Market Outlook: Does aTyr Pharma Inc have pricing powerJuly 2025 Pullbacks & High Conviction Investment Ideas - baoquankhu1.vn

Feb 05, 2026

Feb 05, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: aTyr Pharma (ATYR), Pfizer (PFE) and Bicycle Therapeutics (BCYC) - The Globe and Mail

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CFO Broadfoot sells $1.5k in stock - Investing.com

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CEO Shukla sells $3.6k in stock By Investing.com - Investing.com Nigeria

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CEO Shukla sells $3.6k in stock - Investing.com UK

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CFO Broadfoot sells $1.5k in stock By Investing.com - Investing.com South Africa

Feb 05, 2026

Feb 04, 2026

aTyr Pharma general counsel sells $1091 in stock By Investing.com - Investing.com UK

Feb 04, 2026